For decades, standard cholesterol tests have been the cornerstone of cardiovascular risk assessment, but a growing body of evidence suggests a critical piece of the puzzle has been missing. Cardiologists are now focusing on lipoprotein(a), or Lp(a), a genetically resolute particle that can significantly elevate heart attack and stroke risk even in individuals with healthy lifestyles and “normal” cholesterol levels. An estimated 20% of the global population carries levels of Lp(a) high enough to be considered dangerous – a figure representing nearly 64 million Americans – yet routine screening remains uncommon, leaving millions unaware of their heightened susceptibility. This report examines the emerging understanding of Lp(a) and the implications for preventative cardiology.
Table of Contents
For decades, cardiovascular health has been largely assessed by three key numbers: LDL (“bad”) cholesterol, HDL (“good”) cholesterol, and triglycerides. Reassuringly normal levels of these metrics have often led both patients and doctors to believe their heart health is secure. However, cardiologist Seth J. Baum, MD, argues this approach overlooks a significant, often underestimated risk factor. This finding highlights the importance of a more comprehensive approach to heart disease prevention.
Dr. Baum recently discussed a frequently ignored genetic component: lipoprotein(a), or Lp(a). This particle can silently increase the risk of heart attack, stroke, and aortic valve disease, even in individuals with healthy lifestyles.
“Lp(a) explains a lot of heart disease that people attribute to bad luck. It’s not chance; it’s biology we weren’t measuring,” Dr. Baum explained.
What is Lipoprotein(a)?
Structurally, Lp(a) resembles LDL cholesterol, but it contains an additional protein called apolipoprotein(a). This seemingly small difference has a substantial impact, promoting increased plaque buildup in arteries, inflammation of blood vessels, and blood clot formation.
Unlike LDL, which is influenced by diet, exercise, and medication, Lp(a) is almost entirely determined by genetics. Its levels remain relatively stable throughout life and are not significantly altered by lifestyle choices, leading some experts to refer to it as “genetic cholesterol.”
The numbers are striking: more than 20% of the global population is estimated to have Lp(a) levels high enough to increase cardiovascular risk – roughly one in five adults. In the United States, this equates to nearly 64 million people.
Despite the prevalence, the majority of those at risk have never been tested.
This lack of screening may explain why some individuals experience heart attacks at a young age or despite maintaining a healthy lifestyle. “I see patients who have been told for years that their cholesterol is perfect, only to have a heart attack at 45. When we test for Lp(a), it often provides an explanation,” Dr. Baum said.
An Underestimated Risk Amplifier
Lp(a) acts as a risk multiplier. When levels are elevated, other factors – such as moderately high blood pressure, smoking, borderline high blood sugar, or a sedentary lifestyle – become even more detrimental. Two individuals with the same LDL cholesterol levels can have vastly different cardiovascular outcomes depending on their Lp(a) levels.
This can explain why traditional risk calculators sometimes fail, particularly in patients who experience early-onset events or have a strong family history of heart disease.
According to Dr. Baum, overlooking Lp(a) represents a major blind spot in modern preventative care.
Fortunately, Lp(a) only requires a single test during a lifetime, as its levels remain relatively constant. Values above 50 mg/dL (or 100–125 nmol/L, depending on the testing method) are generally considered concerning.
An elevated Lp(a) level doesn’t guarantee a heart attack, but it does indicate a need for more rigorous prevention strategies. Lp(a) presents a “triple threat” by promoting plaque formation, coagulation, and inflammation.
Despite this, less than 1% of the population has been screened. Some physicians justify the lack of testing by the absence of specific treatments, a rationale Dr. Baum dismisses as unacceptable. “That’s not a valid excuse for ignoring the risk,” he stated.
Reducing Risk Despite Genetic Predisposition
Contrary to common belief, carrying a high Lp(a) level isn’t a life sentence. Dr. Baum emphasizes, “You can’t change your genes, but you can control everything else.”
For patients with elevated Lp(a), LDL cholesterol goals should be more stringent. Levels considered “acceptable” for others may be problematic.
Even mild hypertension, occasional smoking, or poor sleep habits become more significant when Lp(a) is elevated. Every contributing factor adds to the overall risk.
A coronary artery calcium (CAC) scan, a specialized type of CT scan, can directly visualize plaque buildup in the arteries. A high score confirms that the genetic risk has already manifested as disease.
Conversely, a score of zero can be reassuring, particularly in younger individuals.
Because Lp(a) is hereditary, family screening is crucial. Siblings, parents, and children should all be tested. “The youngest family member is often the first to experience an event,” the specialist warned.
Treatments and Future Hope
For severe cases, apheresis – a specialized technique that filters the blood to remove LDL and Lp(a) – is available. However, it’s reserved for patients at very high risk.
More promisingly, several medications currently in advanced clinical trials have demonstrated reductions of 80 to 90% in Lp(a) levels. Approvals could be forthcoming in the coming years, pending robust clinical evidence.
Lipoprotein(a) may explain why some individuals experience heart attacks despite a healthy lifestyle. Frequent, hereditary, and often undetected by standard tests, it can no longer be ignored.
A simple blood test can reveal a hidden risk and potentially reshape a preventative strategy for decades to come.
[cc] Article written by the editorial staff of breizh-info.com and reviewed and corrected (spelling, syntax) by artificial intelligence.
Breizh-info.com, 2026, dispatches free for copying and distribution subject to mandatory mention and do follow link to the original source.
